Literature DB >> 17081620

Perceptual grouping in disorganized schizophrenia.

Peter J Uhlhaas1, William A Phillips, Gordon Mitchell, Steven M Silverstein.   

Abstract

This study evaluated visual perceptual grouping in schizophrenia to test the hypothesis that the disorganization syndrome in schizophrenia is related to a deficit in cognitive coordination. Perceptual grouping was examined with three psychophysically well-controlled tasks in patients with disorganized schizophrenia (n=11), non-disorganized schizophrenia (n=24), psychotic disorders other than schizophrenia (n=31) and non-psychotic psychiatric disorders (n=35). These measures assessed processing of both concurrent and preceding stimulus context. Deficits in perceptual grouping were observed on all three tasks in disorganized schizophrenia patients. Dysfunctional perceptual grouping mechanisms produced both enhanced and impaired task performance suggesting that the pattern of performance observed was the result of a specific deficit in the grouping of stimulus elements. We interpret these data as further support for the hypothesis that the disorganization syndrome in schizophrenia reflects a widespread deficit in the cognitive coordination of contextually related stimuli, leading to dysfunctional grouping of stimulus features in vision, thought and language.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17081620     DOI: 10.1016/j.psychres.2005.10.016

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  75 in total

1.  Schizophrenia patients show augmented spatial frame illusion for visual and visuomotor tasks.

Authors:  Y Chen; R McBain; D Norton; D Ongur
Journal:  Neuroscience       Date:  2010-10-30       Impact factor: 3.590

2.  The clinical translation of a measure of gain control: the contrast-contrast effect task.

Authors:  Deanna M Barch; Cameron S Carter; Steve C Dakin; James Gold; Steven J Luck; Angus Macdonald; John D Ragland; Steven Silverstein; Milton E Strauss
Journal:  Schizophr Bull       Date:  2011-11-17       Impact factor: 9.306

Review 3.  Toward a neurobiology of delusions.

Authors:  P R Corlett; J R Taylor; X-J Wang; P C Fletcher; J H Krystal
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

4.  Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.

Authors:  Joseph Ventura; April D Thames; Rachel C Wood; Lisa H Guzik; Gerhard S Hellemann
Journal:  Schizophr Res       Date:  2010-06-25       Impact factor: 4.939

5.  Ketamine disrupts θ modulation of γ in a computer model of hippocampus.

Authors:  Samuel A Neymotin; Maciej T Lazarewicz; Mohamed Sherif; Diego Contreras; Leif H Finkel; William W Lytton
Journal:  J Neurosci       Date:  2011-08-10       Impact factor: 6.167

6.  Visual context processing in schizophrenia.

Authors:  Eunice Yang; Duje Tadin; Davis M Glasser; Sang Wook Hong; Randolph Blake; Sohee Park
Journal:  Clin Psychol Sci       Date:  2013-01-01

7.  Resting state activity and the "stream of consciousness" in schizophrenia--neurophenomenal hypotheses.

Authors:  Georg Northoff
Journal:  Schizophr Bull       Date:  2014-08-23       Impact factor: 9.306

8.  Is disorganization a feature of schizophrenia or a modifying influence: evidence of covariation of perceptual and cognitive organization in a non-patient sample.

Authors:  Keith A Feigenson; Michael A Gara; Matthew W Roché; Steven M Silverstein
Journal:  Psychiatry Res       Date:  2014-03-12       Impact factor: 3.222

9.  Cognition in schizophrenia and schizo-affective disorder: impairments that are more similar than different.

Authors:  A Owoso; C S Carter; J M Gold; A W MacDonald; J D Ragland; S M Silverstein; M E Strauss; D M Barch
Journal:  Psychol Med       Date:  2013-03-25       Impact factor: 7.723

10.  Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans.

Authors:  Matthew J Baggott; Jennifer D Siegrist; Gantt P Galloway; Lynn C Robertson; Jeremy R Coyle; John E Mendelson
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.